Kiniksa Pharmaceuticals International (KNSA) Revenue (2021 - 2026)
Kiniksa Pharmaceuticals International (KNSA) reported Revenue of $243.6 million for Q2 2026, up 55.4% from $156.8 million a year earlier and up 13.7% from the prior quarter.
Powered by 
Analysis
Kiniksa Pharmaceuticals International (KNSA) Revenue (2021 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Kiniksa Pharmaceuticals International's Revenue came in at $840.85 million, up 58.9% year-over-year; for FY2025, it came in at $677.56 million, up 60.1% from FY2024.
- Revenue has increased for four consecutive years, with a four-year compound annual growth rate of 104.8% (FY2021 to FY2025).
- By year, Revenue came in at $423.24 million in FY2024 (+56.6%), $270.26 million in FY2023 (+22.7%), $220.18 million in FY2022 (+471.2%) and $38.54 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Revenue in data going back to Q2 2021.
- Year over year, Revenue has now increased in each of the last 11 quarters, with growth averaging 58.5% over the last eight quarters.
- The high point for year-over-year Revenue in five years was Q3 2022 (growth of 719.6%); the low point was Q3 2023 (a decline of 32.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $214.27 million (Q1 2026), $202.13 million (Q4 2025) and $180.86 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Kiniksa Pharmaceuticals International | 11.82 Bn | 10.56 Bn | 220.03 Mn | 243.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 243.60 Mn |
| Mar 31, 2026 | 214.27 Mn |
| Dec 31, 2025 | 202.13 Mn |
| Sep 30, 2025 | 180.86 Mn |
| Jun 30, 2025 | 156.80 Mn |
| Mar 31, 2025 | 137.79 Mn |
| Dec 31, 2024 | 122.54 Mn |
| Sep 30, 2024 | 112.21 Mn |
| Jun 30, 2024 | 108.63 Mn |
| Mar 31, 2024 | 79.86 Mn |
| Dec 31, 2023 | 83.40 Mn |
| Sep 30, 2023 | 67.05 Mn |
| Jun 30, 2023 | 71.47 Mn |
| Mar 31, 2023 | 48.35 Mn |
| Dec 31, 2022 | 61.88 Mn |
| Sep 30, 2022 | 99.14 Mn |
| Jun 30, 2022 | 26.97 Mn |
| Mar 31, 2022 | 32.19 Mn |
| Dec 31, 2021 | 18.75 Mn |
| Sep 30, 2021 | 12.10 Mn |
API Access
Kiniksa Pharmaceuticals International Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();